ID.1
Item
for trial part 1, the following applies:
boolean
Gender
Item
gender: male
boolean
C0079399 (UMLS CUI [1])
Age
Item
age: 18-55 years
boolean
C0001779 (UMLS CUI [1])
Body Mass Index
Item
bmi (body mass index): 18-28 kg/m2
boolean
C1305855 (UMLS CUI [1])
Healthy Volunteers
Item
study participants considered to be healthy
boolean
C1708335 (UMLS CUI [1])
ID.6
Item
for trial part 2, the following applies:
boolean
Gender
Item
gender: male or female of no childbearing potential
boolean
C0079399 (UMLS CUI [1])
Age
Item
age: 18-65 years
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent; Body mass index
Item
type 1 diabetes: bmi (body mass index): 18-28 kg/m2
boolean
C0011854 (UMLS CUI [1,1])
C1305855 (UMLS CUI [1,2])
Diabetes Mellitus, Non-Insulin-Dependent; Body mass index
Item
type 2 diabetes: bmi (body mass index): 22-35 kg/m2
boolean
C0011860 (UMLS CUI [1,1])
C1305855 (UMLS CUI [1,2])
Diabetes Mellitus, Insulin-Dependent, Duration; Diabetes Mellitus, Non-Insulin-Dependent, Duration
Item
type 1 or type 2 diabetes for at least 12 months
boolean
C0011854 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
Diabetes Mellitus, Insulin-Dependent; insulin treatment, Duration of therapy
Item
type 1 diabetes: treatment with insulin for at least 12 months
boolean
C0011854 (UMLS CUI [1,1])
C0745343 (UMLS CUI [1,2])
C0444917 (UMLS CUI [1,3])
Diabetes Mellitus, Non-Insulin-Dependent; insulin treatment, Duration of therapy
Item
type 2 diabetes: treatment with insulin for at least 3 months
boolean
C0011860 (UMLS CUI [1,1])
C0745343 (UMLS CUI [1,2])
C0444917 (UMLS CUI [1,3])
Hypersensitivity clinical trial drug; Hypersensitivity Pharmaceutical Preparations Relationships
Item
known or suspected allergy to the trial product or related products
boolean
C0020517 (UMLS CUI [1,1])
C3854006 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
Illness, Interferes with research results; Communicable Diseases, Interferes with research results; Illness, patient safety At risk; Communicable Diseases, patient safety At risk
Item
presence of illness or infection that may confound the results of the study or pose a risk to the study participant by dosing nn1952, as judged by the investigator
boolean
C0221423 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C0009450 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0683954 (UMLS CUI [2,3])
C0221423 (UMLS CUI [3,1])
C1113679 (UMLS CUI [3,2])
C1444641 (UMLS CUI [3,3])
C0009450 (UMLS CUI [4,1])
C1113679 (UMLS CUI [4,2])
C1444641 (UMLS CUI [4,3])
Gastrointestinal symptom Present
Item
presence of acute gastrointestinal symptoms (for example nausea, vomiting, heartburn or diarrhoea)
boolean
C0426576 (UMLS CUI [1,1])
C0150312 (UMLS CUI [1,2])